Lymphokine and phorbol (PMA) regulation of complement (C2) synthesis using U937.
Human monocytes synthesize large amounts of the second complement component (C2) after incubation with a T-lymphocyte product called monocyte complement stimulator (MCS). The human monocyte-like cell line, U937, also synthesizes C2 and can be stimulated to increase this synthesis by lymphokine-rich culture supernates. Additionally, phorbol myristate acetate (PMA), an agent which induces maturational changes in other macrophage-like cell lines, also stimulates C2 synthesis by U937 cells. Lymphokine and PMA stimulation of C2 secretion by U937 are both reversibly inhibitable by cycloheximide. At optimal concentrations for stimulation of C2 synthesis, PMA inhibits [3H]thymidine incorporation by U937 indicating that increased C2 is not due to increased numbers of U937 cells.
D002455:Cell Division; D002460:Cell Line; D003175:Complement C2 / Q000096:biosynthesis*; D003513:Cycloheximide / Q000494:pharmacology; D004121:Dimethyl Sulfoxide / Q000494:pharmacology; D006801:Humans; D008222:Lymphokines / Q000502:physiology*; D009000:Monocytes / Q000166:cytology / Q000276:immunology*; D010704:Phorbols / Q000494:pharmacology*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology*
D003175:Complement C2; D008222:Lymphokines; D010704:Phorbols; D003513:Cycloheximide; D013755:Tetradecanoylphorbol Acetate; D004121:Dimethyl Sulfoxide